Retinal vein cannulation with prolonged infusion of tissue plasminogen activator (t-PA) for the treatment of experimental retinal vein occlusion in dogs

Mohamed K. Tameesh, Rohit R. Lakhanpal, Gildo Y. Fujii, Michael Javaheri, Terry H. Shelley, Sam D'Anna, Aaron C. Barnes, Eyal Margalit, Michel Farah, Eugene De Juan, Mark S. Humayun

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

To evaluate the feasibility, safety, and efficacy of local thrombolytic agents directly injected into occluded retinal veins in an experimental animal model. Experimental animal study. This experimental study was performed in two phases. In phase 1, 15 enucleated porcine eyes and 8 in vivo canine eyes were used for the development of the instrumentation and surgical technique required for retinal vein cannulation with prolonged intravascular infusion. In phase 2 of this study, experimental branch retinal vein occlusion was photo-chemically created using an intravenous injection of rose bengal followed by diode laser photocoagulation in eight eyes of eight dogs. Four eyes were treated by retinal vein cannulation and an injection of tissue plasminogen activator (t-PA) using a specifically designed microcatheter, while the remaining four eyes were untreated (control group). The total amount of t-PA injected intravenously ranged from 400 to 1000 μg, infused over a period ranging from 25 to 45 minutes with a mean pressure of 40 psi, resulting in a mean injection flow rate of 0.05 ml/min. The dogs underwent clinical examination, fluorescein angiography, and histologic examination. Main outcome measures were: Achievement of prolonged intravascular infusion of t-PA, changes in fundus appearance, fluorescein angiography, and histology. A microcatheter instrument and a surgical technique for retinal vein cannulation with prolonged intravascular infusion were developed. Cannulation and t-PA infusion for a period of at least 30 minutes was achieved in all four treated eyes with experimental branch retinal vein occlusion. No complications were recorded in all treated eyes. One week and 1 month postoperatively, treated eyes exhibited marked decreases in retinal hemorrhages, retinal vein dilation, and tortuosity, whereas nontreated eyes exhibited persistence of these findings. Fluorescein angiography demonstrated improved circulatory flow in treated relative to nontreated eyes. Histologic analysis confirmed the presence of thrombi in nontreated eyes only. Retinal vein cannulation with prolonged intravascular injection of t-PA is feasible and safe, and this may offer a new treatment option for retinal vein occlusion.

Original languageEnglish (US)
Pages (from-to)829-839
Number of pages11
JournalAmerican journal of ophthalmology
Volume138
Issue number5
DOIs
StatePublished - Nov 1 2004

Fingerprint

Retinal Vein
Retinal Vein Occlusion
Tissue Plasminogen Activator
Catheterization
Dogs
Fluorescein Angiography
Therapeutics
Injections
Retinal Hemorrhage
Rose Bengal
Semiconductor Lasers
Fibrinolytic Agents
Light Coagulation
Surgical Instruments
Intravenous Injections
Canidae
Dilatation
Histology
Thrombosis
Swine

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Retinal vein cannulation with prolonged infusion of tissue plasminogen activator (t-PA) for the treatment of experimental retinal vein occlusion in dogs. / Tameesh, Mohamed K.; Lakhanpal, Rohit R.; Fujii, Gildo Y.; Javaheri, Michael; Shelley, Terry H.; D'Anna, Sam; Barnes, Aaron C.; Margalit, Eyal; Farah, Michel; De Juan, Eugene; Humayun, Mark S.

In: American journal of ophthalmology, Vol. 138, No. 5, 01.11.2004, p. 829-839.

Research output: Contribution to journalArticle

Tameesh, MK, Lakhanpal, RR, Fujii, GY, Javaheri, M, Shelley, TH, D'Anna, S, Barnes, AC, Margalit, E, Farah, M, De Juan, E & Humayun, MS 2004, 'Retinal vein cannulation with prolonged infusion of tissue plasminogen activator (t-PA) for the treatment of experimental retinal vein occlusion in dogs', American journal of ophthalmology, vol. 138, no. 5, pp. 829-839. https://doi.org/10.1016/j.ajo.2004.06.083
Tameesh, Mohamed K. ; Lakhanpal, Rohit R. ; Fujii, Gildo Y. ; Javaheri, Michael ; Shelley, Terry H. ; D'Anna, Sam ; Barnes, Aaron C. ; Margalit, Eyal ; Farah, Michel ; De Juan, Eugene ; Humayun, Mark S. / Retinal vein cannulation with prolonged infusion of tissue plasminogen activator (t-PA) for the treatment of experimental retinal vein occlusion in dogs. In: American journal of ophthalmology. 2004 ; Vol. 138, No. 5. pp. 829-839.
@article{e540fe499d2b4b0d94f0a7bf9efbbe39,
title = "Retinal vein cannulation with prolonged infusion of tissue plasminogen activator (t-PA) for the treatment of experimental retinal vein occlusion in dogs",
abstract = "To evaluate the feasibility, safety, and efficacy of local thrombolytic agents directly injected into occluded retinal veins in an experimental animal model. Experimental animal study. This experimental study was performed in two phases. In phase 1, 15 enucleated porcine eyes and 8 in vivo canine eyes were used for the development of the instrumentation and surgical technique required for retinal vein cannulation with prolonged intravascular infusion. In phase 2 of this study, experimental branch retinal vein occlusion was photo-chemically created using an intravenous injection of rose bengal followed by diode laser photocoagulation in eight eyes of eight dogs. Four eyes were treated by retinal vein cannulation and an injection of tissue plasminogen activator (t-PA) using a specifically designed microcatheter, while the remaining four eyes were untreated (control group). The total amount of t-PA injected intravenously ranged from 400 to 1000 μg, infused over a period ranging from 25 to 45 minutes with a mean pressure of 40 psi, resulting in a mean injection flow rate of 0.05 ml/min. The dogs underwent clinical examination, fluorescein angiography, and histologic examination. Main outcome measures were: Achievement of prolonged intravascular infusion of t-PA, changes in fundus appearance, fluorescein angiography, and histology. A microcatheter instrument and a surgical technique for retinal vein cannulation with prolonged intravascular infusion were developed. Cannulation and t-PA infusion for a period of at least 30 minutes was achieved in all four treated eyes with experimental branch retinal vein occlusion. No complications were recorded in all treated eyes. One week and 1 month postoperatively, treated eyes exhibited marked decreases in retinal hemorrhages, retinal vein dilation, and tortuosity, whereas nontreated eyes exhibited persistence of these findings. Fluorescein angiography demonstrated improved circulatory flow in treated relative to nontreated eyes. Histologic analysis confirmed the presence of thrombi in nontreated eyes only. Retinal vein cannulation with prolonged intravascular injection of t-PA is feasible and safe, and this may offer a new treatment option for retinal vein occlusion.",
author = "Tameesh, {Mohamed K.} and Lakhanpal, {Rohit R.} and Fujii, {Gildo Y.} and Michael Javaheri and Shelley, {Terry H.} and Sam D'Anna and Barnes, {Aaron C.} and Eyal Margalit and Michel Farah and {De Juan}, Eugene and Humayun, {Mark S.}",
year = "2004",
month = "11",
day = "1",
doi = "10.1016/j.ajo.2004.06.083",
language = "English (US)",
volume = "138",
pages = "829--839",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Retinal vein cannulation with prolonged infusion of tissue plasminogen activator (t-PA) for the treatment of experimental retinal vein occlusion in dogs

AU - Tameesh, Mohamed K.

AU - Lakhanpal, Rohit R.

AU - Fujii, Gildo Y.

AU - Javaheri, Michael

AU - Shelley, Terry H.

AU - D'Anna, Sam

AU - Barnes, Aaron C.

AU - Margalit, Eyal

AU - Farah, Michel

AU - De Juan, Eugene

AU - Humayun, Mark S.

PY - 2004/11/1

Y1 - 2004/11/1

N2 - To evaluate the feasibility, safety, and efficacy of local thrombolytic agents directly injected into occluded retinal veins in an experimental animal model. Experimental animal study. This experimental study was performed in two phases. In phase 1, 15 enucleated porcine eyes and 8 in vivo canine eyes were used for the development of the instrumentation and surgical technique required for retinal vein cannulation with prolonged intravascular infusion. In phase 2 of this study, experimental branch retinal vein occlusion was photo-chemically created using an intravenous injection of rose bengal followed by diode laser photocoagulation in eight eyes of eight dogs. Four eyes were treated by retinal vein cannulation and an injection of tissue plasminogen activator (t-PA) using a specifically designed microcatheter, while the remaining four eyes were untreated (control group). The total amount of t-PA injected intravenously ranged from 400 to 1000 μg, infused over a period ranging from 25 to 45 minutes with a mean pressure of 40 psi, resulting in a mean injection flow rate of 0.05 ml/min. The dogs underwent clinical examination, fluorescein angiography, and histologic examination. Main outcome measures were: Achievement of prolonged intravascular infusion of t-PA, changes in fundus appearance, fluorescein angiography, and histology. A microcatheter instrument and a surgical technique for retinal vein cannulation with prolonged intravascular infusion were developed. Cannulation and t-PA infusion for a period of at least 30 minutes was achieved in all four treated eyes with experimental branch retinal vein occlusion. No complications were recorded in all treated eyes. One week and 1 month postoperatively, treated eyes exhibited marked decreases in retinal hemorrhages, retinal vein dilation, and tortuosity, whereas nontreated eyes exhibited persistence of these findings. Fluorescein angiography demonstrated improved circulatory flow in treated relative to nontreated eyes. Histologic analysis confirmed the presence of thrombi in nontreated eyes only. Retinal vein cannulation with prolonged intravascular injection of t-PA is feasible and safe, and this may offer a new treatment option for retinal vein occlusion.

AB - To evaluate the feasibility, safety, and efficacy of local thrombolytic agents directly injected into occluded retinal veins in an experimental animal model. Experimental animal study. This experimental study was performed in two phases. In phase 1, 15 enucleated porcine eyes and 8 in vivo canine eyes were used for the development of the instrumentation and surgical technique required for retinal vein cannulation with prolonged intravascular infusion. In phase 2 of this study, experimental branch retinal vein occlusion was photo-chemically created using an intravenous injection of rose bengal followed by diode laser photocoagulation in eight eyes of eight dogs. Four eyes were treated by retinal vein cannulation and an injection of tissue plasminogen activator (t-PA) using a specifically designed microcatheter, while the remaining four eyes were untreated (control group). The total amount of t-PA injected intravenously ranged from 400 to 1000 μg, infused over a period ranging from 25 to 45 minutes with a mean pressure of 40 psi, resulting in a mean injection flow rate of 0.05 ml/min. The dogs underwent clinical examination, fluorescein angiography, and histologic examination. Main outcome measures were: Achievement of prolonged intravascular infusion of t-PA, changes in fundus appearance, fluorescein angiography, and histology. A microcatheter instrument and a surgical technique for retinal vein cannulation with prolonged intravascular infusion were developed. Cannulation and t-PA infusion for a period of at least 30 minutes was achieved in all four treated eyes with experimental branch retinal vein occlusion. No complications were recorded in all treated eyes. One week and 1 month postoperatively, treated eyes exhibited marked decreases in retinal hemorrhages, retinal vein dilation, and tortuosity, whereas nontreated eyes exhibited persistence of these findings. Fluorescein angiography demonstrated improved circulatory flow in treated relative to nontreated eyes. Histologic analysis confirmed the presence of thrombi in nontreated eyes only. Retinal vein cannulation with prolonged intravascular injection of t-PA is feasible and safe, and this may offer a new treatment option for retinal vein occlusion.

UR - http://www.scopus.com/inward/record.url?scp=7544239918&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7544239918&partnerID=8YFLogxK

U2 - 10.1016/j.ajo.2004.06.083

DO - 10.1016/j.ajo.2004.06.083

M3 - Article

C2 - 15531319

AN - SCOPUS:7544239918

VL - 138

SP - 829

EP - 839

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

SN - 0002-9394

IS - 5

ER -